Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients

per Wang, Ling-Zhi, Ramírez, Jacqueline, Yeo, Winnie, Chan, Mei-Yi Michelle, Thuya, Win-Lwin, Lau, Jie-Ying Amelia, Wan, Seow-Ching, Wong, Andrea Li-Ann, Zee, Ying-Kiat, Lim, Robert, Lee, Soo-Chin, Ho, Paul C., Lee, How-Sung, Chan, Anthony, Ansher, Sherry, Ratain, Mark J., Goh, Boon-Cher
Publicat 2013

Correction: Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients

per Wang, Ling-Zhi, Ramírez, Jacqueline, Yeo, Winnie, Chan, Mei-Yi Michelle, Thuya, Win-Lwin, Lau, Jie-Ying Amelia, Wan, Seow-Ching, Wong, Andrea Li-Ann, Zee, Ying-Kiat, Lim, Robert, Lee, Soo-Chin, Ho, Paul C., Lee, How-Sung, Chan, Anthony, Ansher, Sherry, Ratain, Mark J., Goh, Boon-Cher
Publicat 2014

Implementation of Timeline Reforms Speeds Initiation of National Cancer Institute–Sponsored Trials

per Abrams, Jeffrey S., Mooney, Margaret M., Zwiebel, James A., Korn, Edward L., Friedman, Steven H., Finnigan, Shanda R., Schettino, Patricia R., Denicoff, Andrea M., Kruhm, Martha G., Montello, Mike, Misra, R. Rita, Ansher, Sherry S., DiPiazza, Kate J., Souhan, Erin M., Wickerham, D. Lawrence, Giantonio, Bruce J., O’Donnell, Robert T., Sullivan, Daniel M., Soto, Nancy I., Fleming, Gini F., Prindiville, Sheila A., Petryshyn, Ray A., Hautala, Judith A., Grad, Oren, Zuckerman, Brian L., Meyer, Ralph M., Yao, James C., Baker, Laurence A., Buckner, Jan C., Hortobagyi, Gabriel N., Doroshow, James H.
Publicat 2013